Ledger entry · candidate

Fezolinetant → Insomnia — Audit-grade candidate (scan)

Drug: fezolinetant · AE: Insomnia

Discovered via single-drug scan of fezolinetant. PRR = 3.10 (95% CI 2.53–3.81), n = 87 cases. Pre-reg locked at submission time.

Disproportionality

Top reactions in cohort

MedDRA PTn
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.